280 related articles for article (PubMed ID: 25912737)
1. Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model.
Liu XL; Hu JY; Hu MY; Zhang Y; Hong ZY; Cheng XQ; Chen J; Pang DW; Liang Y
Biochim Biophys Acta; 2015 Aug; 1852(8):1561-73. PubMed ID: 25912737
[TBL] [Abstract][Full Text] [Related]
2. Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells.
Hu JY; Zhang DL; Liu XL; Li XS; Cheng XQ; Chen J; Du HN; Liang Y
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):414-427. PubMed ID: 27890528
[TBL] [Abstract][Full Text] [Related]
3. Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau.
Meng SR; Zhu YZ; Guo T; Liu XL; Chen J; Liang Y
PLoS One; 2012; 7(6):e38903. PubMed ID: 22701727
[TBL] [Abstract][Full Text] [Related]
4. Protein disulfide isomerase interacts with tau protein and inhibits its fibrillization.
Xu LR; Liu XL; Chen J; Liang Y
PLoS One; 2013; 8(10):e76657. PubMed ID: 24098548
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two VQIXXK motifs for tau fibrillization in vitro.
Li W; Lee VM
Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091
[TBL] [Abstract][Full Text] [Related]
6. Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.
Shimonaka S; Matsumoto SE; Elahi M; Ishiguro K; Hasegawa M; Hattori N; Motoi Y
J Biol Chem; 2020 Oct; 295(41):13996-14014. PubMed ID: 32759167
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
KrishnaKumar VG; Paul A; Gazit E; Segal D
Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
[TBL] [Abstract][Full Text] [Related]
8. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
9. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
[TBL] [Abstract][Full Text] [Related]
10. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
11. Pin1 allows for differential Tau dephosphorylation in neuronal cells.
Hamdane M; Dourlen P; Bretteville A; Sambo AV; Ferreira S; Ando K; Kerdraon O; Bégard S; Geay L; Lippens G; Sergeant N; Delacourte A; Maurage CA; Galas MC; Buée L
Mol Cell Neurosci; 2006; 32(1-2):155-60. PubMed ID: 16697218
[TBL] [Abstract][Full Text] [Related]
12. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
13. Different tau epitopes define Abeta42-mediated tau insolubility.
Pennanen L; Götz J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1097-101. PubMed ID: 16226718
[TBL] [Abstract][Full Text] [Related]
14. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
15. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.
Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY
J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664
[TBL] [Abstract][Full Text] [Related]
16. A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.
Stöhr J; Wu H; Nick M; Wu Y; Bhate M; Condello C; Johnson N; Rodgers J; Lemmin T; Acharya S; Becker J; Robinson K; Kelly MJS; Gai F; Stubbs G; Prusiner SB; DeGrado WF
Nat Chem; 2017 Sep; 9(9):874-881. PubMed ID: 28837163
[TBL] [Abstract][Full Text] [Related]
17. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
18. In vitro tau fibrillization: mapping protein regions.
Santa-María I; Pérez M; Hernández F; Muñoz V; Moreno FJ; Avila J
Biochim Biophys Acta; 2006 Jul; 1762(7):683-92. PubMed ID: 16891100
[TBL] [Abstract][Full Text] [Related]
19. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
20. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.
Wang YP; Biernat J; Pickhardt M; Mandelkow E; Mandelkow EM
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10252-7. PubMed ID: 17535890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
